A phase 1b, randomized, open-label, single blind, study to evaluate the tolerability, safety and dose finding of oil cannabis preparation for pain in Parkinson's disease

Authors
Category Primary study
ConferenceMovement Disorders Clinical Practice
Year 2022
This article has no abstract
Epistemonikos ID: 91d9cdaf89065bcab54f3162399fc2bdf7635794
First added on: Apr 30, 2026